Skip to main content
In stock|Immunotherapy (Gene Therapy)

Nadofaragene Firadenovec

Oncology TypeSolid Tumour
Drug Class / MechanismNon-Replicating Adenoviral Vector Delivering Interferon Alfa-2b
No Image
Description

Nadofaragene Firadenovec is classified as a Non-Replicating Adenoviral Vector Delivering Interferon Alfa-2b, sourced for use within our Immunotherapy (Gene Therapy) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryImmunotherapy (Gene Therapy)
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3